Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600125816Phase 4Not yet recruiting
Phase 4, randomised, single-blind trial of fospropofol disodium (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Bispectral Index (BIS) and Drug dose. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600125816.